EA200000762A1 - Способ для консервации органов или других тканей для трансплантации - Google Patents

Способ для консервации органов или других тканей для трансплантации

Info

Publication number
EA200000762A1
EA200000762A1 EA200000762A EA200000762A EA200000762A1 EA 200000762 A1 EA200000762 A1 EA 200000762A1 EA 200000762 A EA200000762 A EA 200000762A EA 200000762 A EA200000762 A EA 200000762A EA 200000762 A1 EA200000762 A1 EA 200000762A1
Authority
EA
Eurasian Patent Office
Prior art keywords
transplantation
tissues
organs
organ
conservation
Prior art date
Application number
EA200000762A
Other languages
English (en)
Inventor
Лоренс Д. Хорвитц
Original Assignee
Борд Оф Риджентс Оф Зе Юниверсити Оф Колорадо
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Борд Оф Риджентс Оф Зе Юниверсити Оф Колорадо filed Critical Борд Оф Риджентс Оф Зе Юниверсити Оф Колорадо
Publication of EA200000762A1 publication Critical patent/EA200000762A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyurethanes Or Polyureas (AREA)

Abstract

Настоящее изобретение относится к способу консервации живых тканей для трансплантации. Используемые соединения защищают ткани от вредного воздействия активных форм кислорода. Способ для консервации органов или других тканей для трансплантации заключается в добавлении к органу или ткани раствора для консервации, содержащего соединение формулы I или фармацевтически приемлемой его соли в количестве, эффективном для консервации органаМеждународная заявка была опубликована вместе с отчетом о международном поиске.
EA200000762A 1996-02-09 1997-02-07 Способ для консервации органов или других тканей для трансплантации EA200000762A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/598,926 US5670545A (en) 1996-02-09 1996-02-09 Method for the treatment of ischemic disease and reperfusion injury and the prevention of the adverse effects of reactive oxygen species
PCT/US1997/002024 WO1997028792A1 (en) 1996-02-09 1997-02-07 Traitement and prevention of adverse effects of reactive oxygen species

Publications (1)

Publication Number Publication Date
EA200000762A1 true EA200000762A1 (ru) 2001-04-23

Family

ID=24397503

Family Applications (2)

Application Number Title Priority Date Filing Date
EA199800665A EA001800B1 (ru) 1996-02-09 1997-02-07 Способы лечения и предупреждения неблагоприятного воздействия активных форм кислорода
EA200000762A EA200000762A1 (ru) 1996-02-09 1997-02-07 Способ для консервации органов или других тканей для трансплантации

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EA199800665A EA001800B1 (ru) 1996-02-09 1997-02-07 Способы лечения и предупреждения неблагоприятного воздействия активных форм кислорода

Country Status (13)

Country Link
US (2) US5670545A (ru)
EP (1) EP0910355B1 (ru)
JP (1) JP2001500104A (ru)
CN (1) CN1097457C (ru)
AT (1) ATE227125T1 (ru)
AU (1) AU713754B2 (ru)
CA (1) CA2246236C (ru)
CZ (1) CZ291763B6 (ru)
DE (1) DE69716914T2 (ru)
EA (2) EA001800B1 (ru)
ES (1) ES2185909T3 (ru)
HU (1) HUP9901969A3 (ru)
WO (1) WO1997028792A1 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391899B1 (en) * 1998-07-17 2002-05-21 North Shore—Long Island Jewish Research Institute Compounds and compositions for treating tissue ischemia
EP1475434A1 (en) 2003-05-09 2004-11-10 Oncoscience AG Method for storing tumor cells
US8735154B2 (en) 2006-10-30 2014-05-27 The University Of Kansas Templated islet cells and small islet cell clusters for diabetes treatment
US20090263780A1 (en) * 2008-04-17 2009-10-22 Yanming Wang Organ preservation fluid
WO2010014953A1 (en) * 2008-08-01 2010-02-04 The Regents Of The University Of Colorado, A Body Corporate Prolonged administration of a dithiol anti-oxidant protects against ventricular remodeling
WO2013016544A2 (en) 2011-07-27 2013-01-31 University Of Kansas Templated islet cells and small islet cell clusters for diabetes treatment
WO2023184031A1 (en) * 2022-03-30 2023-10-05 Revive Therapeutics Ltd Method and use of bucillamine in the prevention and treatment of stroke

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51148090A (en) * 1975-06-12 1976-12-18 Santen Pharmaceut Co Ltd Process for stabilizing an aqueous lysozyme solution
JPS535112A (en) * 1976-03-08 1978-01-18 Santen Pharmaceutical Co Ltd New cysteine derivatives
US4053651A (en) * 1976-05-10 1977-10-11 E. R. Squibb & Sons, Inc. Compounds and method for alleviating angiotensin related hypertension
JPS545916A (en) * 1977-06-17 1979-01-17 Santen Pharmaceutical Co Ltd Novel cystein derivative
JPS5912119B2 (ja) * 1977-10-29 1984-03-21 参天製薬株式会社 アミノ酸誘導体の製造方法
JPS6058908B2 (ja) * 1978-10-11 1985-12-23 参天製薬株式会社 システイン誘導体
JPS5551021A (en) * 1978-10-11 1980-04-14 Santen Pharmaceut Co Ltd Remedy for hepatic disorder
JPS6011888B2 (ja) * 1978-10-11 1985-03-28 参天製薬株式会社 リウマチ疾患治療薬
JPS5756454A (en) * 1980-09-20 1982-04-05 Santen Pharmaceut Co Ltd Disulfide type cysteine derivative
US5292926A (en) * 1988-01-25 1994-03-08 Santen Pharmaceutical Co., Ltd. Cysteine derivatives
JPH04154714A (ja) * 1990-10-17 1992-05-27 Shiseido Co Ltd 毛髪還元剤及び毛髪化粧料
JP2816500B2 (ja) * 1990-10-17 1998-10-27 参天製薬株式会社 抗骨粗鬆剤
JP3066608B2 (ja) * 1991-01-16 2000-07-17 参天製薬株式会社 腎疾患治療剤
JP2814033B2 (ja) * 1992-01-10 1998-10-22 参天製薬株式会社 シスチン尿症治療剤
JP2843955B2 (ja) * 1992-08-01 1999-01-06 参天製薬株式会社 抗白内障剤
JP2899740B2 (ja) * 1994-02-08 1999-06-02 参天製薬株式会社 炎症性腸疾患治療剤

Also Published As

Publication number Publication date
CN1097457C (zh) 2003-01-01
EP0910355B1 (en) 2002-11-06
DE69716914D1 (de) 2002-12-12
US5756547A (en) 1998-05-26
EA199800665A1 (ru) 1999-08-26
DE69716914T2 (de) 2003-07-03
CA2246236A1 (en) 1997-08-14
AU713754B2 (en) 1999-12-09
ATE227125T1 (de) 2002-11-15
HUP9901969A2 (hu) 1999-11-29
EP0910355A4 (ru) 1999-04-28
EA001800B1 (ru) 2001-08-27
CN1210461A (zh) 1999-03-10
ES2185909T3 (es) 2003-05-01
JP2001500104A (ja) 2001-01-09
AU2264497A (en) 1997-08-28
US5670545A (en) 1997-09-23
CZ246998A3 (cs) 1998-11-11
HUP9901969A3 (en) 2001-08-28
EP0910355A1 (en) 1999-04-28
CZ291763B6 (cs) 2003-05-14
CA2246236C (en) 2006-12-19
WO1997028792A1 (en) 1997-08-14

Similar Documents

Publication Publication Date Title
EA200000409A1 (ru) Соединение, фармацевтическая композиция, способ ингибирования гибели клетки в одной клетке или ткани, способ лечения или снижения клеточной смерти, способ лечения или профилактики поликистозного заболевания почек или анемии/эритропоэза у животных, способ защиты органа или ткани млекопитающего от гибели клеток, способ снижения или профилактики гибели клеток в органе или ткани донора после их трансплантации, способ снижения или предотвращения гибели спермы или яйцеклеток
SE8401177D0 (sv) Novel azole compounds
DE122005000058I1 (de) Depsipeptide, Herstellung und Anwendung
SE7806939L (sv) Retentionspreparat for tandproteser
BR0314699A (pt) Composto, composição e métodos para o tratamento da dor e para inibição da função vr1 em uma célula
RU94044436A (ru) Способы подавления атрофии кожи и влагалища
ATE399782T1 (de) Zur behandlung von schmerzen geeignete phenylcarbonsäureamidverbindungen
IL207923A0 (en) Metal-binding compounds and uses therefor
EA199801036A1 (ru) Консерванты для древесины
DK0659417T3 (da) Fremgangsmåder til inhibering af dysfunktionel blødning fra livmoderen
DE69426855T2 (de) Verwendung von 2-phenyl-3-aroylbenzothiophen Derivaten zur Herstellung eines Medikaments zur Hemmung des Knorpelabbaus
EA200000762A1 (ru) Способ для консервации органов или других тканей для трансплантации
AR017904A1 (es) Mezclas fungicidas y procedimentos para controlar hongos nocivos que las emplean.
BR9711160A (pt) Composições farmacêuticas para neutralizar danosss a células ou tecido, prcoessos para o tratamento de indivìduo para neutralizar danos a células, tecido ou órgão e para a conservação ex vivo de 'rogão, tecido ou células, e, composto.
EA199800019A1 (ru) Способ повышения плотности кальциевых каналов
PT959683E (pt) Composicoes sinergicas antimicrobianas que contem 1-hidroxi-metil-pirazol e um agente conservante
EA199700136A1 (ru) Способы ингибирования экзогенных эстрогенов
EA200100584A1 (ru) Фосфорорганические соединения и их применение
ATE282314T1 (de) R-metalaxyl enthaltende fungizide zusammensetzungen
ATE179300T1 (de) Lungentransplantat-konservierungsmittelmischung und verfahren zur lebendkonservierung von lungentransplantaten
DK0594942T3 (da) N-Aminoalkylcarbonyloxyalkylpyrroler som insekticide, acaricide og molluskicide midler
HUT53264A (en) Fungicide compositions containing sulfurian acrilic ester derivatives as active components and process for producing the active components
DK363383A (da) Fungicide midler
SE8702422D0 (sv) Improvements in or relating to fungicides
DK0594940T3 (da) N-Oxy- og thioalkylcarbonyloxyalkylpyrroler som insekticide, acaricide og molluskicide midler